Related Experiment Video
Updated: Feb 11, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
Published on: May 21, 2019
Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome
Muhammad Arba1, Andry Nur-Hidayat1, Ruslin1
1Faculty of Pharmacy, Halu Oleo University, Kendari, 93231, Indonesia.
Abstract:
The ubiquitin-proteasome system plays an important role in protein quality control. Currently, inhibition of the proteasome has been validated as a promising approach in anticancer therapy. The 20S core particle of the proteasome harbors β5 subunit which is a crucial active site in proteolysis. Targeting proteasome β5 subunit which is responsible for the chymotrypsin-like activity of small molecules has been regarded as an important way for achieving therapeutics target. In the present study, a series of porphyrin derivatives bearing either pyridine or pyrazole rings as meso-substituents were designed and evaluated as an inhibitor for the β5 subunit of the proteasome by employing molecular docking and dynamics simulations. The molecular docking was performed with the help of AutoDock 4.2, while molecular dynamics simulation was done using AMBER 14. All compounds bound to the proteasome with similar binding modes, and each porphyrin-proteasome complex was stable during 30 ns MD simulation as indicated by root-mean-square-deviation (RMSD) value. An analysis on protein residue fluctuation of porphyrin binding demonstrates that in all complexes, porphyrin binding produces minor fluctuation on amino acid residues. The molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) free energy calculation shows that the binding affinities of mono-H2PyP, bis-H2PzP, and tetra-H2PyP were comparable with that of the potential inhibitor, HU10. It is noted that the electrostatic interaction increases with the number of meso-substituents, which was favourable for porphyrin binding. The present study shows that both electrostatic and van der Waals interaction are the main force which controls the interaction of porphyrin compounds with the proteasome.
Insights
New porphyrin derivatives show promise as proteasome inhibitors for cancer therapy. These compounds target the proteasome
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- The ubiquitin-proteasome system is vital for protein quality control.
- Proteasome inhibition is a validated anticancer therapy strategy.
- The proteasome's β5 subunit is a key target for therapeutic intervention.
Purpose of the Study:
- To design and evaluate novel porphyrin derivatives as inhibitors of the proteasome β5 subunit.
- To investigate the binding modes and stability of porphyrin-proteasome complexes.
- To assess the binding affinities and key interactions driving porphyrin compound binding.
Main Methods:
- Molecular docking simulations using AutoDock 4.2.
- Molecular dynamics simulations using AMBER 14.
- MM-PBSA free energy calculations to determine binding affinities.
Main Results:
- Porphyrin derivatives exhibited stable binding to the proteasome with minor effects on protein residue fluctuation.
- Binding affinities of selected compounds (mono-H2PyP, bis-H2PzP, tetra-H2PyP) were comparable to a known inhibitor (HU10).
- Increased meso-substituents enhanced electrostatic interactions, favoring porphyrin binding.
Conclusions:
- Porphyrin derivatives are effective inhibitors of the proteasome β5 subunit.
- Electrostatic and van der Waals interactions are crucial for porphyrin-proteasome binding.
- These findings support the development of porphyrin-based therapeutics for cancer treatment.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Molecular Models
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
The Proteasome Structure
The proteasome is an...

